BRD2 Antibody - C-terminal region : FITC (ARP34211_T100-FITC)

Product Specifications

Gene Name

Bromodomain containing 2

Gene Aliases

FSH, NAT, RNF3, FSRG1, RING3, D6S113E, O27.1.1, BRD2-IT1

Gene ID

6046

Swiss Prot

P25440

Accession Number

NP_005095

Host

Rabbit

Reactivity

Human, Mouse, Rat, Cow, Dog, Guinea Pig, Horse

Immunogen

The immunogen is a synthetic peptide directed towards the C terminal region of human BRD2

Target

BRD2 is a mitogen-activated kinase which localizes to the nucleus. The gene maps to the major histocompatability complex (MHC) class II region on chromosome 6p21.3 but sequence comparison suggests that the protein is not involved in the immune response. Homology to the Drosophila gene female sterile homeotic suggests that this human gene may be part of a signal transduction pathway involved in growth control.

Partner Proteins

CSNK2A2; BRD7; ELAVL1; UBC; HIST1H4A; HIST2H2BE; TERF2; tat; TBP; E2F1; BRD2; HIST2H4A; HIST3H2BB; E2F2; RB1; KDM5A; RBL2

Clonality

Polyclonal

Conjugation

FITC: Fluorescein Isothiocyanate

Type

Polyclonal Antibody

Applications

Sample Type

BRD2 is strongly supported by BioGPS gene expression data to be expressed in Jurkat

Concentration

0.5 mg/ml

Homology

Cow: 92%; Dog: 93%; Guinea Pig: 93%; Horse: 93%; Human: 100%; Mouse: 93%; Rat: 93%

Format

Liquid. Purified antibody supplied in 1x PBS buffer.

Reconstitution

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.